Publications en collaboration avec des chercheurs de Imperial College London (35)

2024

  1. Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table

    Journal of Clinical Lipidology

2021

  1. Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR

    New England Journal of Medicine, Vol. 385, Núm. 23, pp. 2150-2160

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603

  2. ESC core curriculum for the cardiologist

    European Heart Journal, Vol. 41, Núm. 38, pp. 3605-3692

  3. Long-term outcomes of chronic coronary syndrome worldwide: Insights from the international CLARIFY registry

    European Heart Journal, Vol. 41, Núm. 3, pp. 347-355

  4. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)

    European Journal of Heart Failure, Vol. 22, Núm. 9, pp. 1504-1524

2019

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

    European Respiratory Journal, Vol. 54, Núm. 3

  2. Correction to: Cost‑effectiveness analysis of stand‑alone or combined non‑invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study (The European Journal of Health Economics, (2019), 20, 9, (1437-1449), 10.1007/s10198-019-01096-5)

    European Journal of Health Economics

  3. Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study

    European Journal of Health Economics, Vol. 20, Núm. 9, pp. 1437-1449

  4. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180

2018

  1. 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

    European Heart Journal, Vol. 39, Núm. 14, pp. 1131-1143

  2. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis

    European Heart Journal, Vol. 39, Núm. 15, pp. 1224-1245

  3. Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 20, Núm. 12, pp. 1615-1633

  4. Multimodality Imaging in Restrictive Cardiomyopathies: An European Association of Cardiovascular Imaging Expert Consensus Document in Collaboration with the 'Working Group on Myocardial and Pericardial Diseases' of the European Society of Cardiology Endorsed by the Indian Academy of Echocardiography

    Journal of the Indian Academy of Echocardiography and Cardiovascular Imaging, Vol. 2, Núm. 1, pp. 19-44

  5. New prospects for PCSK9 inhibition?

    European heart journal

  6. State of play and future direction with NOACs: An expert consensus

    Vascular Pharmacology, Vol. 106, pp. 9-21

2017

  1. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement

    Journal of the American College of Cardiology, Vol. 69, Núm. 16, pp. 2067-2087

  2. Evolocumab and clinical outcomes in patients with cardiovascular disease

    New England Journal of Medicine, Vol. 376, Núm. 18, pp. 1713-1722

  3. Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the "Working Group on myocardial and pericardial diseases" of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography

    European Heart Journal Cardiovascular Imaging, Vol. 18, Núm. 10, pp. 1090-1091

2016

  1. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients with Stable Angina

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 36, Núm. 4, pp. 757-764